Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy
Blood (2019) 134 (Supplement_1): 122.
Currently there are no citedby results. Try again later.
